Wnt signaling in colorectal cancer: pathogenic role and therapeutic target

H Zhao, T Ming, S Tang, S Ren, H Yang, M Liu, Q Tao… - Molecular cancer, 2022 - Springer
Abstract Background The Wnt signaling pathway is a complex network of protein interactions
that functions most commonly in embryonic development and cancer, but is also involved in …

The functional roles of the circRNA/Wnt axis in cancer

C Xue, G Li, Q Zheng, X Gu, Z Bao, J Lu, L Li - Molecular Cancer, 2022 - Springer
CircRNAs, covalently closed noncoding RNAs, are widely expressed in a wide range of
species ranging from viruses to plants to mammals. CircRNAs were enriched in the Wnt …

Signaling pathways governing breast cancer stem cells behavior

K Song, M Farzaneh - Stem Cell Research & Therapy, 2021 - Springer
Breast cancer is the second common cancer and the leading cause of malignancy among
females overall. Breast cancer stem cells (BCSCs) are a small population of breast cancer …

Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy

M Van Trimpont, E Peeters, Y De Visser, AM Schalk… - Cancers, 2022 - mdpi.com
Simple Summary L-asparaginase (L-ASNase) therapy is key for achieving the very high cure
rate of pediatric acute lymphoblastic leukemia (ALL), yet its use is mostly confined to this …

[HTML][HTML] A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer

H Kumar, NV Gupta, R Jain… - Journal of Advanced …, 2023 - Elsevier
Background Triple-negative breast cancer (TNBC) is a heterogeneous, aggressive
phenotype of breast cancer with associated chemoresistance. The development of chemo-or …

Therapeutic progress and challenges for triple negative breast cancer: Targeted therapy and immunotherapy

R Yang, Y Li, H Wang, T Qin, X Yin, X Ma - Molecular biomedicine, 2022 - Springer
Triple negative breast cancer (TNBC) is a subtype of breast cancer, with estrogen receptor,
human epidermal growth factor receptor 2 and progesterone receptor negative. TNBC is …

Curcumin: modulator of key molecular signaling pathways in hormone-independent breast cancer

R Farghadani, R Naidu - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer remains the most commonly diagnosed cancer and the
leading cause of cancer death among females worldwide. It is a highly heterogeneous …

Triple-negative breast cancer: understanding Wnt signaling in drug resistance

P Merikhian, MR Eisavand, L Farahmand - Cancer cell international, 2021 - Springer
Triple-negative breast cancer (TNBC) is not as prevalent as hormone receptor or HER2-
positive breast cancers and all receptor tests come back negative. More importantly, the …

Immunotherapy in breast cancer: when, how, and what challenges?

B Henriques, F Mendes, D Martins - Biomedicines, 2021 - mdpi.com
Breast Cancer (BC) is the second most frequent cause of cancer death among women
worldwide and, although there have been significant advances in BC therapies, a significant …

Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways

Y Wang, S Li, M Hu, Y Yang, E McCabe… - Nature …, 2024 - nature.com
The efficacy of STING (stimulator of interferon genes) agonists is due to various factors,
primarily inefficient intracellular delivery, low/lack of endogenous STING expression in many …